重新利用非必不可少的氨基酸 γ-氨基黄油酸治疗多药耐药细菌
Yuexiao Jia1, Zhencheng Sun2, Ke Zhang2
1School of Medical and Health Engineering, Changzhou University, Changzhou, Jiangsu 213164, P. R. China.
ACS applied materials & interfaces
|February 6, 2026
概括
研究人员通过封装金纳米粒子 (Au NPs) 来重新利用氨基酸-氨基黄油酸 (GABA) 来产生Au_GABA. 这种新型药物有效地对抗多药耐药细菌,提供了一个有前途的新疗法候选者.
科学领域:
- 纳米技术 纳米技术
- 微生物学 微生物学
- 生物化学 生物化学
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球健康的重大威胁,需要新的抗菌策略.
- 黄金纳米粒子 (Au NPs) 提供了多功能平台,用于开发新的抗菌剂,因为它们的可调整表面特性.
研究的目的:
- 通过使Au NPs.功能化,将非必不可少的氨基酸玛-氨基黄油酸 (GABA) 作为抗菌剂重新利用.
- 评估GABA封顶Au NPs (Au_GABA) 对多药耐药 (MDR) 细菌的疗效和机制.
主要方法:
- 合成和表征GABA封顶Au NPs (Au_GABA) 的情况.
- 对Au_GABA的抗菌谱对抗格拉姆阳性和格拉姆阴性MDR细菌菌株的评估,包括耐卡巴胺的肠杆菌 (CRE) 和耐甲林的黄金葡萄球菌 (MRSA).
- 研究Au_GABA的作用机制,包括产生活性氧物种 (ROS) 和对细菌细胞膜的影响.
- 对MDR细菌感染的Au_GABA体内治疗疗效的评估.
主要成果:
- Au_GABA对各种MDR细菌表现出广泛的抗菌活性.
- 该机制涉及通过ROS促进诱导核酸的氧化损伤和破坏细菌细胞膜.
- 在体内研究证实了Au_GABA在治疗MDR细菌感染中的卓越疗效.
结论:
- GABA-capped Au NPs (Au_GABA) 是一种新且有效的治疗候选物,用于对抗MDR细菌感染.
- 这项研究突出了氨基酸在抗菌疗法和纳米粒子功能化中的新应用.
相关概念视频
Amino acids
105.7K
Amino acids are the monomers that comprise proteins. Each amino acid has the same fundamental structure, which consists of a central carbon atom, or the alpha (α) carbon, bonded to an amino group (NH2), a carboxyl group (COOH), and to a hydrogen atom. Every amino acid also has another atom or group of atoms bonded to the central atom known as the R group. There are 20 common amino acids present in proteins, each with a different R group. Variation in the amino acid sequence is responsible for...
105.7K
Amino Acid Catabolism
1.2K
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
1.2K
Amino Acid Biosynthetic Pathways
1.2K
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.2K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
996
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
996
Polyprotic Acids
32.1K
Acids are classified by the number of protons per molecule that they can give up in a reaction. Acids such as HCl, HNO3, and HCN that contain one ionizable hydrogen atom in each molecule are called monoprotic acids. Their reactions with water are:
32.1K
Mixtures of Acids
21.9K
The pH of a solution containing an acid can be determined using its acid dissociation constant and its initial concentration. If a solution contains two different acids, then its pH can be determined using one of several methods depending upon the relative strength of the acids and their dissociation constants.
A Mixture of a Strong Acid and a Weak Acid
In a mixture of a strong acid and a weak acid, the strong acid dissociates completely and becomes a source of almost all the hydronium ions...
A Mixture of a Strong Acid and a Weak Acid
In a mixture of a strong acid and a weak acid, the strong acid dissociates completely and becomes a source of almost all the hydronium ions...
21.9K


